Publications by authors named "M Delforge"

Claim this Profile
S
Sequencing BCMA- and GPRC5D-targeting immunotherapies in multiple myeloma: Practical guidance from the European Myeloma Network.
Niels W C J van de Donk, Philippe Moreau, Jesus F San-Miguel, Maria-Victoria Mateos, Meletios A Dimopoulos, Michel Delforge

Hemasphere· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients and healthcare professionals' perspectives on the implementation of shared decision making in multiple myeloma: a multinational qualitative study.
Elise Schoefs, Charlotte Verbeke, Jolien Broekmans, Silène Ten Seldam, Kate Morgan, Michel Delforge

BMC Med Inform Decis Mak· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunophenotypic changes in the tumor and tumor microenvironment during progression to multiple myeloma.
Isabelle Bergiers, Murat Cem Köse, Sheri Skerget, Milan Malfait, Nele Fourneau, Michel Delforge

PLoS Genet· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A plain language summary of LocoMMotion - an observational study of treatments used for pretreated multiple myeloma.
Michel Delforge, Eilidh Duncan, María-Victoria Mateos, Imène Haddad, Wafae Iraki

Future Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating tumor cells predict myeloma outcomes in patients treated with daratumumab, bortezomib, lenalidomide, and dexamethasone.
Luca Bertamini, Cathelijne Fokkema, Paula Rodriguez-Otero, Mark van Duin, Evangelos Terpos, Michel Delforge

Blood· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis